688193 Stock Overview
Engages in the development and promotion of RNA molecular diagnostic technology and products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Shanghai Rendu Biotechnology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥38.14 |
| 52 Week High | CN¥50.30 |
| 52 Week Low | CN¥23.00 |
| Beta | 0.21 |
| 1 Month Change | -6.75% |
| 3 Month Change | 3.64% |
| 1 Year Change | 15.44% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -41.11% |
Recent News & Updates
Shanghai Rendu Biotechnology Co., Ltd.'s (SHSE:688193) Business Is Trailing The Industry But Its Shares Aren't
Feb 10
What Shanghai Rendu Biotechnology Co., Ltd.'s (SHSE:688193) 26% Share Price Gain Is Not Telling You
Nov 05Recent updates
Shanghai Rendu Biotechnology Co., Ltd.'s (SHSE:688193) Business Is Trailing The Industry But Its Shares Aren't
Feb 10What Shanghai Rendu Biotechnology Co., Ltd.'s (SHSE:688193) 26% Share Price Gain Is Not Telling You
Nov 05A Look At The Intrinsic Value Of Shanghai Rendu Biotechnology Co., Ltd. (SHSE:688193)
Oct 16There Are Some Holes In Shanghai Rendu Biotechnology's (SHSE:688193) Solid Earnings Release
May 06We Like These Underlying Return On Capital Trends At Shanghai Rendu Biotechnology (SHSE:688193)
Apr 17What Shanghai Rendu Biotechnology Co., Ltd.'s (SHSE:688193) 29% Share Price Gain Is Not Telling You
Mar 08Shareholder Returns
| 688193 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -3.5% | -2.7% | -2.1% |
| 1Y | 15.4% | -7.3% | 11.6% |
Return vs Industry: 688193 exceeded the CN Medical Equipment industry which returned -7.3% over the past year.
Return vs Market: 688193 exceeded the CN Market which returned 11.6% over the past year.
Price Volatility
| 688193 volatility | |
|---|---|
| 688193 Average Weekly Movement | 5.5% |
| Medical Equipment Industry Average Movement | 4.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 3.4% |
Stable Share Price: 688193 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688193's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 368 | Minghui Yu | www.rdbio.com |
Shanghai Rendu Biotechnology Co., Ltd. engages in the development and promotion of RNA molecular diagnostic technology and products. The company offers products in the areas of reproductive health, respiratory diseases, enterovirus, food safety, and blood infectious diseases, as well as automatic nucleic acid detection and analysis system. The company was founded in 2007 and is based in Shanghai, China.
Shanghai Rendu Biotechnology Co., Ltd. Fundamentals Summary
| 688193 fundamental statistics | |
|---|---|
| Market cap | CN¥1.48b |
| Earnings (TTM) | -CN¥7.38m |
| Revenue (TTM) | CN¥177.35m |
8.3x
P/S Ratio-200.1x
P/E RatioIs 688193 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688193 income statement (TTM) | |
|---|---|
| Revenue | CN¥177.35m |
| Cost of Revenue | CN¥0 |
| Gross Profit | CN¥177.35m |
| Other Expenses | CN¥184.73m |
| Earnings | -CN¥7.38m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Apr 30, 2025
| Earnings per share (EPS) | -0.19 |
| Gross Margin | 100.00% |
| Net Profit Margin | -4.16% |
| Debt/Equity Ratio | 0.5% |
How did 688193 perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield55%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/23 01:36 |
| End of Day Share Price | 2025/03/21 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shanghai Rendu Biotechnology Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.